Literature DB >> 7656236

Isolation and characterization of human breast cancer cells overexpressing S-adenosylmethionine decarboxylase.

A Manni1, B Badger, R Grove, S Kunselman, L Demers.   

Abstract

We report the first successful isolation and initial characterization of S-adenosylmethionine decarboxylase (SAMDC)-overexpressing cells using a transfection approach. Stably transfected MCF-7 breast cancer overproducing SAMDC (approximately 5-fold) manifested reduced ornithine decarboxylase while levels of N'-spermidine/spermine acetyltransferase were variably increased. Analysis of cellular polyamine profile showed that spermine was selectively increased (approximately 80%), while spermidine and putrescine levels were reduced (approximately 48% and approximately 15% of control, respectively). Since SAMDC-overexpressing clones exhibited increased clonogenicity in soft agar, our data suggest that spermine may be selectively involved in conferring a more invasive phenotype to breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7656236     DOI: 10.1016/0304-3835(95)03860-y

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Transgenic mice overexpressing ornithine and S-adenosylmethionine decarboxylases maintain a physiological polyamine homoeostasis in their tissues.

Authors:  R Heljasvaara; I Veress; M Halmekytö; L Alhonen; J Jänne; P Laajala; A Pajunen
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

2.  Treatment of prostate cancer cells with adenoviral vector-mediated antisense RNA using androgen-dependent and androgen-independent promoters.

Authors:  Wei Li
Journal:  Med Oncol       Date:  2009-06-11       Impact factor: 3.064

3.  K-FGF mediated transformation and induction of metastatic potential involves altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression--role in cellular invasion.

Authors:  Marcus S Hardin; Rene Mader; Robert A R Hurta
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.